Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$340,866
+$14,898 QoQ
Shares Held
2,175
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#1,063
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prospect Financial Group LLC holds $2,219,700 across 5 Drug Manufacturers - General names. NVS ranks #4 (15.4% of the industry book) .
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $340,866 | 2,175 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $325,968 | 2,134 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $294,214 | 2,134 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $273,664 | 2,134 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $258,235 | 2,134 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $237,675 | 2,132 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $206,978 | 2,127 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||